Detection of Neurodegenerative Diseases by Spectroscopic Techniques
Not Applicable
- Conditions
- Health Condition 1: G301- Alzheimers disease with late onsetHealth Condition 2: G20- Parkinsons disease
- Registration Number
- CTRI/2024/05/067873
- Lead Sponsor
- Manipal Academy of Higher Education, Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
(1) Subjects with age (20-60 yrs.)
without PD and AD.
(2) Both sex is included.
(3) Subjects without any chronic
complications are included.
(4)Subjects without Parkinson and Alzheimer
and any other systemic diseases
such as diabetes were included.
Exclusion Criteria
(1) Subjects who did not accept voluntarily to
sign the consent form were excluded.
(2) Subjects with any health complications and
infectious disorders are excluded.
(3) Pregnant women are excluded.
(4) Subjects with Smoking and alcohol
consumption/HIV/Cancer/Hepatitis/
autoimmune disorders excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study is designed for the detection of protein biomarkers in subjects with neurodegenerative disorders by fluorescence spectroscopyTimepoint: Baseline for Control <br/ ><br>Baseline for Test
- Secondary Outcome Measures
Name Time Method Standardization of deviceTimepoint: 12 Months;To detect protein aggregates in Alzheimer’s and Parkinson’s diagnosis and controls <br/ ><br> <br/ ><br>Timepoint: 12 months